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Abstract
Hepatotoxicity is one of the most common side effects of methotrexate (MTX) therapy in patients. The aim of this study was to 
evaluate the protective effect of vitamin E against MTX-induced hepatotoxicity using 99mTc-phytate as a radiopharmaceutical 
agent in animals. Rats were divided into five groups as follows: control, solvent, Vit E (100 mg/kg), MTX (20 mg/kg) and Vit E + 
MTX. Animals were intraperitoneally injected with Vit E for 17 days before MTX injection and continued for 4 days. 99mTc-phytate 
was injected into the tail of rats after the 21 days of Vit E administration. Percentage of the injected dose per gram of liver and 
spleen tissues (%ID/g) was calculated in treated rats. Liver imaging was obtained with gamma camera. In other experiment, 
liver of treated rats was assessed for histopathology. 99mTc-phytate uptake (%ID/g) of livers in control, solvent, Vit E, MTX and 
Vit E + MTX groups were 8.99% ± 1.37, 8.53% ± 2.91, 8.65% ± 3.84, 3.22% ± 1.09 and 8.38% ± 2.68. Vit E administration 
resulted in a significant increase of the level of %ID/g in MTX-injected animal. Vit E pre-treatment improved the shape of liver 
in MTX-treated rat which was seen abnormal view in planar imaging. Histophatological examinations approved the protective 
effect of Vit E against MTX-induced hepatotoxicity in rats. The results of this study show that Vit E significantly attenuates the 
MTX-induced hepatotoxicity in rats, and 99mTc-phytate is an acceptable radiopharmaceutical agent for assessment of liver and 
spleen damages in the animal model.
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Introduction
Methotrexate (MTX) is a folic acid antagonist which has been 
widely used as an effective anticancer agent in chemotherapy regi-
men [1]. It has been prescribed extensively as a cytotoxic agent in 
the treatment of leukemia, breast cancer, testicular tumors and other 
malignancies. It is used in psoriasis and rheumatoid arthritis that 
are inflammatory related diseases [2–4]. MTX causes some toxic 
effects including nausea, vomiting, diarrhea, alopecia, stomatitis, 
bone marrow depression and hepatotoxicity in patients [5]. MTX 
treatment increases biomarkers associated with liver injury and are 
involving in hepatotoxicity [6]. MTX inhibits enzymes corresponding 
in production of the main sources of nicotine amide adenine dinu-
cleotide (NADPH) resulting in intracellular decreases of NADPH [7]. 
Following NADPH decreasing, glutathione decreases and hepato-
cytes become vulnerable against reactive oxygen species (ROS). 
Enhancement of ROS level causes oxidative stress in cell [8]. 
Hepatotoxicity and production of ROS are main side effects induced 
by MTX [9]. Then it has been advised to prevent MTX-induced hepa-
totoxicity, it is using concomitant with antioxidants [10]. Several pro-
tective agents such as penthoxyphyllin, alpha lipoic acid and beta 
carotenes have been investigated in different studies for prevention 
of MTX-caused hepatotoxicity [10, 11]. Vitamin E is considered a li-
pid soluble vitamin and an important antioxidant. This vitamin is able 
to neutralize peroxide and free radicals. Vitamin E protects cellular 
membrane against oxidative damages [12]. Vitamin E, as a free 
radical scavenger, protects cellular organelles against harmful ef-
fects of free radicals [13].
99mTc-phytate colloid is a radiopharmaceutical agent that 
has been used for functional imaging of liver and spleen in nuclear 
medicine. Since 1973, 99mTc-phytate has been used as an imaging 
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radiotracer for liver and spleen assessments. Most of the colloid 
particles are captured by the Kupffer cells in the liver which is well 
imaged in nuclear medicine practice [14, 15]. Radionuclide distribu-
tion in the liver has a great relevance with chronic hepatic disease 
severity, histological fibrosis severity and hepatic functions. So, 
quantitative evaluation of 99mTc-phytate uptake in liver could be 
used as a hepatic function tool [16].
The purpose of this research was to evaluate the protective 
effect of vitamin E on hepatic and spleen injuries caused by MTX 
using quantitative 99mTc-phytate uptake measurements and planar 
imaging and then radiopharmaceutical findings were compared 
with pathological data in rat.
Material and methods
Animal
Wistar rats weighing 180 ± 220 g were purchased from the 
Pasteur Institute (Amol, Iran). Rats were housed in a good condi-
tion in the university animal house and given standard mouse pellet 
and water ad Libitum. Animals were kept under controlled lighting 
condition (light: dark, 12:12 h) and temperature (22 ± 1°C). Ani-
mal experimental and ethical issues were approved by Research 
Committee of Mazandaran University of Medical Sciences, Sari, 
Iran (ID# 1969). 
Chemicals
MTX was purchased from Myian (2 mg/2 mL vial, France). 
Vitamin E (Vit E), as injection form in olive oil, was from Osvaeh 
Pharmaceutical Co. (Iran). All other chemicals were obtained from 
Merck Company (Germany). 
Experimental group and treatment schedules
Twenty animals were randomly divided into 5 groups (four 
rats each group):
 — Group 1: control; the rats were administered daily intraperitoneal 
(ip) of normal saline for 21 days;
 — Group 2: solvent; the rats were administered daily intraperito-
neal (ip) of olive oil for 21 days;
 — Groups 3: Vit E; the rats were treated with Vit E (100 mg kg–1 
bw) for 21 days;
 — Group 4: MTX; the rats were administered a single dose of MTX 
ip injections (20 mg kg–1 body weight (bw)) at 17 days after olive 
oil treatment and 4 days before killing;
 — Groups 5: Vit E+ MTX; rats were injected with Vit E (100 mg 
kg–1 bw) at 21 days before single dose of MTX treatment and 
continued for 4 days. 
Radiopharmaceutical assessment
99mTc, as sodium pertechnetate, was eluted from a 99Mo/99mTc 
generator (IEOI, Iran) just before the radiolabelling procedure. 
Phytate (IEOI, Iran) was used as a freeze-dried commercial kit. 
99mTc-phytate was prepared by adding 740 MBq of 99mTc-pertech-
netate to 3.5 mL of saline to the kit. Radiolabelling was performed 
according to manufacture guideline. After slowly shaking, it is kept at 
room temperature for 15 minute. 99mTc-phytate (0.1 mL) was injected 
through the tail vein. After deep anesthesia (by ketamine/xylazine), 
rats were killed and the livers and spleens were removed by dis-
section 2 hours after the radiopharmaceutical injection. Livers and 
spleens were weighed in pre-weighed containers. Radioactivity in 
each organ samples was counted using a gamma counter (Delshid, 
Iran). The percentage of injected dose per gram of tissue (%ID/g) 
was calculated by dividing the radioactivity count per minute in each 
tissue by total count injected and the mass of the organ.
Scintigraphic imaging with 99mTc-phytate
Planar imaging studies were performed on anesthetized rats to 
obtain a visual confirmation of the liver uptakes and shapes. Im-
ages were acquired at 2 hours postinjection of 99mTc-phytate using 
an E-CAM dual head (Siemens Medical Solutions, Hoffman Estates, 
IL) equipped with a low energy high-resolution collimator.
Histopathological assessment
After fixation the liver tissue in 10% formalin, samples were pro-
cessed according to standard histological techniques and embed-
ded in paraffin blocks. Paraffin blocks were sectioned using a rotary 
microtome into 3 µm thick sections placed on glass slides and fixed 
for histological staining. Staining was performed using hematoxylin. 
Liver tissue was evaluated on hepatic paranchyme showing mor-
phological changes. The tissue sections were assessed by blinded 
pathologist. The average of ten microscopic fields was recorded 
by him for each specimen. Histopathological criteria and the mor-
phological parameters were defined semi-quantitatively according 
to modified scoring system [17, 18] which performed as follow:
(-), (+-), (+), (++), and (+++) is indicating: no or absent, 
few or < 1 single altered foci into microscopic HPF (High Power 
Field ×400), mild or between 1 ≤ 2 altered foci in 10 microscopic 
HPF, moderate or between 2–3 altered foci in to microscopic HPF, 
and severe or > 3 altered foci in to microscopic HPF, respectively.
Statistical analysis
The data values are presented as means ± standard deviation 
(SD). Statistical analysis was performed using one-way analysis of 
variance (ANOVA), as well as post hoc Dunnett’s Multiple Compari-
son Test. P value < 0.05 was considered as significant and highly 
significant, respectively (Prism Software, USA).
Results
Quantitation of liver and spleen uptakes  
of 99mTc-phytate
The percentage of the injected dose per gram of 99mTc-phytate 
in liver of control, solvent, Vit E, MTX, and Vit E + MTX groups were 
8.99% ± 1.37, 8.53% ± 2.91, 8.65% ± 3.84, 3.22% ± 1.09 and 
8.38% ± 2.68 (Figure 1A). MTX injection reduced 99mTc-phytate 
uptake in liver as compared with other groups as control, solvent 
and Vit E. It was observed significant difference between MTX 
group and other groups in ID/g% values of livers (P < 0.05). Vit E 
pre-treatment significantly increased the 99mTc-phytate uptake in 
the livers of rats injected by MTX. The mean of ID/g% value in liver 
was significantly higher in Vit E + MTX group as compared with 
MTX treatment alone group (P < 0.05). The ID/g% of 99mTc-phytate in 
spleen of control, solvent, Vit E, MTX, and Vit E + MTX groups were 
4.00% ± 1.07, 5.19% ± 1.34, 4.40% ± 2.11, 1.86% ± 0.49 and 
2.94% ± 0.98 (Figure 1B). It was observed a significant differ-
ence between MTX group with solvent and Vit E groups in ID/g% 
values (P < 0.05). The 99mTc-phytate spleen uptake was about 2.7 
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fold less in MTX treatment group as compared to solvent group 
(P < 0.05). However Vit E pre-treatment increased the 99mTc-phytate 
uptake in the spleens of rats injected by MTX, the mean of ID/g% 
value in spleen was statistically non significantly higher in Vit 
E + MTX group as compared with MTX treatment alone group. 
Gamma camera imaging
The whole body images of treated rats are presented in Figure 2. 
The hepatic uptakes of 99mTc-phytate were homogeneous in control, 
solvent and Vit E treated rats. The shape of liver was abnormal in 
MTX-injected rat. The uptake of 99mTc-phytate was concentrated 
as a circle or round shape. It is interesting that the Vit E pre-treat-
ment improved the shape of liver in planar image.
Histopathological assessment
The impaired hepatic caused by MTX was further confirmed by 
histological examination of liver (Fig. 3). As shown in Figure 3, liver 
sections from control, solvent and Vit E in rats showed normality 
whereas liver in animals treated with MTX revealed a marked liver 
necrosis and degeneration, extensive epithelial vacuolization, swell-
ing and dilation (Fig. 3). The hepatic damage was less severe in 
the rat treated with Vit E + MTX when compared with MTX-treated 
alone rat (Fig. 3). The histopathological alteration semi-quantitative 
results of some injury related parameters are shown in Table 1. 
Histological evaluations of the liver sections of animals from control, 
solvent and Vit E groups showed normal structure, architectural 
integrity and regenerative nodules. The animals from MTX group 
Figure 1. The percentage of the injected 99mTc-phytate dose per gram 
of liver (A) and spleen (B) tissues (% ID/g) in control, solvent (olive oil), 
vitamin E (100 mg/kg), methotrexate (MTX), vitamin E + methotrexate 
(Vit E + MTX) groups are shown (n = 4). *Comparison of all groups 
with MTX groups P < 0.05, non-significant comparison of control, 
solvent, Vit E and Vit E + MTX between groups. # Comparison 
of solvent and Vit E with MTX groups P < 0.05, non-significant 
comparison of control and Vit E + MTX with MTX
Figure 2. Whole body images of rats were injected 99mTc-phytate. Rats are as control, solvent, Vit E, methotrexate (MTX), Vit E + MTX. The uptakes 
of 99mTc-phytat in control, solvent and Vit E and also Vit E + MTX are homogenous while scintigraphic imaging shows an abnormal shape of liver in 
MTX-treated rat
Figure 3. Histological examination of rats treated with methotroxate (MTX) and/or vitamin E (Vit E). The liver of control, solvent and Vit E treated rats show 
normal. Liver of rat administered with MTX at a single dose of 20 mg/Kg exhibited a distinct histological difference when compared with control, these liver 
shows large numbers of cells with degeneration. Improved cellular degeneration was seen in rat treated with Vit E at dose 100 mg/Kg and MTX
11www.journals.viamedica.pl/nuclear_medicine_review
Hossein Amirfakhrian et al., Hepatoprotective effect of vitamin E
Original
exhibited histopathological alterations, with variations in the number 
of pathological criteria such as of congestion, dilatation, apoptotic 
and cytoplasmic and endothelial cell injury (Table 1). Vit E + MTX 
group showed preserved liver architecture with markedly reduction 
in number of pathological alterations. 
Discussion
It is important to recognize and understand the side effect 
of chemotherapy on the liver, since this is a major organ which 
is responsible for drug, endogenous and exogenous substan-
ces clearance. Since some chemotherapeutic agents such as MTX 
may cause liver damage, the evaluation of possible hepatotoxicity 
is important in healthcare. In this study, hepatoprotective effect 
of Vit E after a single injection of MTX was evaluated in rats. MTX 
induced significantly live damage that was prevented by Vit E treat-
ment. The hepatotoxicity was evaluated using 99mTc-phytate that 
is used as a radiopharmaceutical agent for assessment of hepatic 
and spleen diseases in patients. This protective effect was con-
firmed with histopathology. This is the first time study to investigate 
using MTX in treatment with Vit. E in animals that was verified 
with a radionuclide method using 99mTc-phytate as a radioactive 
colloid radiopharmaceutical. Hepatotoxicity is a common side 
effect caused by MTX in patients [19, 20]. Elevated ROS and 
induced pro-inflammatory process are main suggested mecha-
nisms involved in hepatotoxicity induced by MTX [21]. Several 
compounds have been reported to have protective effect against 
hepatotoxicity induced by MTX. These compounds acted mainly 
through antioxidant and anti-inflammatory effects [22–24]. Our 
findings showed that MTX significantly reduced the liver uptake 
of 99mTc-phytate about 2.5-fold less level than control rats. The 
present results show that MTX causes Kupffer cell malfunction 
in the liver and these damaged cells unable to uptake normally 
this radiopharmaceutical agent. Also the reduction in uptake of 
99mTc-phytate was observed in spleen of MTX-treated rats. The 
reticuloendothelial system (RES) plays an important role in the 
biological defense system. Kupffer cells are the main constitu-
ent of the RES in the liver and spleen, and when their function 
is impaired post drug treatment the complications may occur 
[25, 26]. 99mTc-phytate is used for imaging areas of functional 
reticuloendothelial cells in the liver, spleen and bone marrow. It 
is a useful radiopharmaceutical agent in the diagnosis, localization 
and evaluation of liver and spleen pathology. In the blood, phytic 
acid binds with calcium ions to form colloidal particles which are 
captured by the RES, principally by Kupffer cells in the liver. In 
imaging purpose, 99mTc-phytate reacts in vivo with calcium ions in 
the blood and forms 99mTc-Sn-Ca-phytate that is rapidly cleared 
by the RES from the blood. Uptake of the radioactive colloid by 
RES is dependent upon both the relative blood flow rates and the 
functional capacity of the phagocytic cells [27]. In a study, the side 
effect of ionizing radiation on the liver in rat was evaluated using 
gamma camera (99mTc-phytate) imaging and MRI [28]. Exposure 
to ionizing radiation (4 Gy) markedly induced liver injury that 
was visualized by gamma scintigraphy with changing in the shape 
of the liver and the relative proportions of the volumes of its right 
and left portions that these findings were confirmed by MRI and 
pathology. Both techniques proved that the reticuloendothelial 
cells were damaged by ionizing radiation, which might result in 
malfunction of the Kupffer cells and or a decrease in their num-
ber [28]. Histological findings of MTX-induced hepatotoxicity are 
including macrovesicular steatosis, hepatocellular necrosis and in-
flammation, edema, fibrosis, morphological abnormalities and de-
velopment of cirrhosis [29–31]. Chemotherapeutic agents caused 
drug induced acute hepatitis and hepatomegaly, decreased liver 
enhancement and widening of periportal space due to edema 
which are nonspecific imaging findings of acute hepatitis [32]. In 
our study an abnormal shape of liver in MTX-treated animal that 
attributed liver pathologic abnormalities was observed.
Table 1. The effect of vitamin E (Vit E) against hepatotoxicity induced by methotrexate (MTX) 
Criteria
Group Control Solvent Vit E MTX Vit E + MTX
Change in architecture - - - + -
Congestion - +,- +,- +++ ++
Dilation - +,- +,- +++ +
PMNS - +,- + +++ +
Mononuclears - - +,- ++ +
Eosinophills - - - ++ -
Necrosis - - +,- + +,-
Apoptosis - - - ++ +
Cytoplasmic - - +,- ++ +
Hydropic degeneration - - +,- ++ +
Activated kupffer cell - - +,- ++ +
Fatty change macrovesicular steatosis - ++ +,- - -
Uncertain cellular limit - +,- +,- ++ +,-
Tronbosis - - - ++ +
Endothelial cells injuries - - ++ +,-
(-), (+,-), (+), (++), and (+++) is indicating: no or absent, few or < 1 single altered foci in to microscopic HPF (High Power Field *400), mild or between 1 ≤ 2 altered foci in 10 microscopic 
HPF, moderate or between 2–3 altered foci in to 10 microscopic HPF, and severe or > 3 altered foci in to 10 microscopic HPF, respectively
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 In this study, Vit E administration increased the liver uptake of 
99mTc-phytate in rats injected with MTX, and the level of radioactivity 
uptake was close to normal range. It was interesting that the shape 
of liver was changed in MTX-injected rat and liver was an abnormal 
shape. While the shape of liver in Vit E + MTX treated rat was similar 
to control rat. It was a confirmation in liver damages assessment 
between quantitation of liver uptake of 99mTc-phytate and liver image. 
Pathological examination confirmed that MTX significantly caused 
hepatotoxicity in rats that this liver damage was prevented by Vit 
E treatment. Vit E exhibited hepatoprotective effect in rats that 
co-injected with MTX. Vit E has free radical scavenging, increasing 
endogenous antioxidant and anti-inflammatory effects [33, 34]. 
These mechanisms are suggested to contribute in reduction of 
deleterious effects of MTX in liver and spleen by Vit E.
Conclusion
In this study, it was demonstrated the Vit E was effective in 
the prevention of hepatotoxicity induced by MTX in animal. Our 
results showed that quantization of injected dose per gram of 
99mTc-phytate in liver and spleen as well as liver image to be accept-
able techniques for assessment of liver and spleen damages and/or 
their tissues protective effects in animal model.
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